Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

Takeda announced positive late-stage results for its new type 2 diabetes drug, fasiglifam (TAK-875), the first GPR40 agonist to reach late-stage development. Fasiglifam has the potential to be a ...

Diabetic nephropathy has five stages that describe the progression of the disease from least to most severe. Diabetic nephropathy, also known as diabetic kidney disease, is a slowly progressing ...

Charcot foot is an uncommon deformity of the foot that happens because of nerve damage, often from diabetes. In Charcot foot, the bones and joints of the foot become damaged and do not heal properly.

Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and ...

Dr. Bianca Hemmingsen is Technical Lead – Diabetes, Department of Noncommunicable Diseases and Mental Health, World Health Organization (WHO); Ms. Sanjana Marpadga is a Technical Officer – Diabetes, ...